Geode Capital Management, LLC Oncocyte Corp Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.2 - $0.35 $47,219 - $82,634	236,099 Added 23.79%	1,228,553 $282,000
Q4 2022 Feb 13, 2023	SELL	$0.25 - $0.69 $625 - $1,724	-2,500 Reduced 0.25%	992,454 $318,000
Q3 2022 Nov 14, 2022	BUY	$0.76 - $0.99 $16,440 - $21,415	21,632 Added 2.22%	994,954 $726,000
Q2 2022 Aug 12, 2022	SELL	$0.86 - $1.53 $252,087 - $448,481	-293,125 Reduced 23.15%	973,322 $875,000
Q1 2022 May 13, 2022	BUY	$1.15 - $2.25 $54,099 - $105,846	47,043 Added 3.86%	1,266,447 $1.89 Million

Q4 2021 Feb 11, 2022	BUY	$2.04 - $3.59 $127,642 - $224,626	62,570 Added 5.41%	1,219,404 $2.65 Million
Q3 2021 Nov 12, 2021	SELL	$3.53 - $5.89 $214,052 - $357,157	-60,638 Reduced 4.98%	1,156,834 $4.12 Million
Q2 2021 Aug 13, 2021	BUY	$3.77 - $6.0 $288,005 - $458,364	76,394 Added 6.69%	1,217,472 $6.99 Million
Q1 2021 May 12, 2021	BUY	$2.39 - $6.5 $916,127 - $2.49 Million	383,317 Added 50.59%	1,141,078 $5.92 Million
Q4 2020 Feb 12, 2021	BUY	$1.38 - $2.63 $233,818 - $445,611	169,434 Added 28.8%	757,761 $1.81 Million
Q3 2020 Nov 13, 2020	BUY	$1.2 - $1.89 $132,885 - $209,294	110,738 Added 23.19%	588,327 $817,000
Q2 2020 Aug 13, 2020	BUY	$1.91 - $3.45 $286,941 - $518,296	150,231 Added 45.89%	477,589 $912,000
Q1 2020 May 14, 2020	BUY	$1.76 - $3.02 $25,683 - $44,070	14,593 Added 4.67%	327,358 $802,000
Q4 2019 Feb 13, 2020	BUY	$1.51 - $2.27 $10,680 - $16,055	7,073 Added 2.31%	312,765 $703,000
Q3 2019 Nov 12, 2019	BUY	$1.59 - $2.51 $432 - $682	272 Added 0.09%	305,692 $641,000
Q2 2019 Aug 14, 2019	BUY	$2.49 - $5.45 $319,240 - $698,739	128,209 Added 72.35%	305,420 $760,000
Q1 2019 May 14, 2019	BUY	$1.47 - $5.91 $237,787 - $956,001	161,760 Added 1046.92%	177,211 $699,000
Q3 2018 Nov 13, 2018	SELL	$2.2 - $3.45 $204 - $320	-93 Reduced 0.6%	15,451 $38,000
Q2 2018 Aug 14, 2018	SELL	$2.0 - $3.3 $16,622 - $27,426	-8,311 Reduced 34.84%	15,544 $39,000
Q1 2018 May 15, 2018	BUY	$1.25 - $4.6 $2,095 - $7,709	1,676 Added 7.56%	23,855 $50,000
Q4 2017 Feb 13, 2018	BUY	$3.9 - $7.4 $635 - $1,206	163 Added 0.74%	22,179 $103,000
Q3 2017 Nov 14, 2017	BUY	$4.55 - $7.55 $2,466 - $4,092	542 Added 2.52%	22,016 $166,000
Q2 2017 Aug 14, 2017	BUY	N/A	21,474	21,474 $111,000

Others Institutions Holding OCX

# of Institutions

Shares Held

1.16M

Call Options Held

Put Options Held

View Full List

About Oncocyte Corp

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $350M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

More about OCX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account